Fidelity Investments’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152M | Buy |
|
|||||
|
2025
Q1 | $130M | Buy |
|
|||||
|
2024
Q4 | $146M | Buy |
|
|||||
|
2024
Q3 | $161M | Buy |
|
|||||
|
2024
Q2 | $133M | Sell |
|
|||||
|
2024
Q1 | $110M | Buy |
|
|||||
|
2023
Q4 | $71.4M | Buy |
|
|||||
|
2023
Q3 | $50.2M | Sell |
|
|||||
|
2023
Q2 | $81.7M | Buy |
|
|||||
|
2023
Q1 | $69.3M | Buy |
|
|||||
|
2022
Q4 | $390K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $696K | Sell |
|
|||||
|
2021
Q4 | $4.52M | Sell |
|
|||||
|
2021
Q3 | $9.43M | Sell |
|
|||||
|
2021
Q2 | $20.9M | Buy |
|
|||||
|
2021
Q1 | $19M | Sell |
|
|||||
|
2020
Q4 | $57.6M | Buy |
|
|||||
|
2020
Q3 | $50.4M | Buy |
|
|||||
|
2020
Q2 | $45.7M | Buy |
|
|||||
|
2020
Q1 | $17.2M | Buy |
|